PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 149 filers reported holding PTC THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,672,772 | -49.9% | 74,644 | -9.0% | 0.00% | -40.0% |
| Q2 2023 | $3,335,835 | -17.0% | 82,022 | -1.1% | 0.01% | -16.7% |
| Q1 2023 | $4,019,115 | +25.2% | 82,971 | -1.3% | 0.01% | +20.0% |
| Q4 2022 | $3,208,952 | -23.0% | 84,070 | +1.3% | 0.01% | -28.6% |
| Q3 2022 | $4,166,000 | +22.6% | 82,988 | -2.2% | 0.01% | +40.0% |
| Q2 2022 | $3,399,000 | +7.9% | 84,853 | +0.5% | 0.01% | +25.0% |
| Q1 2022 | $3,151,000 | -13.6% | 84,448 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $3,645,000 | +9.4% | 91,503 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $3,331,000 | -17.7% | 89,521 | -6.5% | 0.00% | -20.0% |
| Q2 2021 | $4,048,000 | -8.3% | 95,773 | +2.8% | 0.01% | -16.7% |
| Q1 2021 | $4,412,000 | -22.7% | 93,186 | -0.4% | 0.01% | -25.0% |
| Q4 2020 | $5,709,000 | +30.4% | 93,547 | -0.1% | 0.01% | +14.3% |
| Q3 2020 | $4,378,000 | -7.4% | 93,637 | +0.5% | 0.01% | -12.5% |
| Q2 2020 | $4,728,000 | +15.4% | 93,175 | +1.5% | 0.01% | -11.1% |
| Q1 2020 | $4,096,000 | -7.6% | 91,808 | -0.5% | 0.01% | +12.5% |
| Q4 2019 | $4,431,000 | +46.8% | 92,263 | +3.4% | 0.01% | +33.3% |
| Q3 2019 | $3,018,000 | -23.9% | 89,240 | +1.2% | 0.01% | -25.0% |
| Q2 2019 | $3,968,000 | +33.8% | 88,174 | +11.9% | 0.01% | +33.3% |
| Q1 2019 | $2,965,000 | +21.8% | 78,765 | +11.1% | 0.01% | 0.0% |
| Q4 2018 | $2,434,000 | -25.3% | 70,914 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $3,257,000 | +39.4% | 69,288 | -0.0% | 0.01% | +20.0% |
| Q2 2018 | $2,337,000 | +41.5% | 69,292 | +13.5% | 0.01% | +25.0% |
| Q1 2018 | $1,652,000 | +56.7% | 61,064 | -3.4% | 0.00% | +100.0% |
| Q4 2017 | $1,054,000 | -17.9% | 63,205 | -1.5% | 0.00% | -33.3% |
| Q3 2017 | $1,284,000 | +18.7% | 64,160 | +8.7% | 0.00% | +50.0% |
| Q2 2017 | $1,082,000 | +67.8% | 59,041 | -9.9% | 0.00% | +100.0% |
| Q1 2017 | $645,000 | -13.7% | 65,541 | -4.2% | 0.00% | -50.0% |
| Q4 2016 | $747,000 | -24.1% | 68,441 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $984,000 | +100.8% | 70,241 | +0.7% | 0.00% | +100.0% |
| Q2 2016 | $490,000 | +6.3% | 69,741 | -2.7% | 0.00% | 0.0% |
| Q1 2016 | $461,000 | -77.3% | 71,660 | +14.3% | 0.00% | -80.0% |
| Q4 2015 | $2,032,000 | +23.5% | 62,719 | +1.8% | 0.01% | +25.0% |
| Q3 2015 | $1,645,000 | -44.7% | 61,619 | -0.3% | 0.00% | -42.9% |
| Q2 2015 | $2,975,000 | +9.3% | 61,819 | +38.2% | 0.01% | +16.7% |
| Q1 2015 | $2,722,000 | +15.5% | 44,726 | -1.8% | 0.01% | 0.0% |
| Q4 2014 | $2,357,000 | +30.5% | 45,526 | +10.9% | 0.01% | +50.0% |
| Q3 2014 | $1,806,000 | +70.5% | 41,033 | +1.3% | 0.00% | +33.3% |
| Q2 2014 | $1,059,000 | +96.8% | 40,500 | +96.6% | 0.00% | +200.0% |
| Q1 2014 | $538,000 | +83.0% | 20,600 | +19.1% | 0.00% | 0.0% |
| Q4 2013 | $294,000 | -0.7% | 17,300 | +25.4% | 0.00% | 0.0% |
| Q3 2013 | $296,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |